Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 2, Number 4—October 1996
Dispatch

Assessing the Costs and Benefits of an Oral Vaccine for Raccoon Rabies: A Possible Model

Martin I. Meltzer
Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 2

Threshold price for the oral vaccine at different levels of bait density and three distribution costs:cost-savings ratios for the expanding circles scenario Notes: Threshold price occurs at the point that the net present value of a vaccination program = $0. The distribution costs:cost-savings ratios are calculated on a per unit area basis, using the maximum cost-savings figures (i.e., savings resulting from avoiding an epizootic).

Figure 2. Threshold price for the oral vaccine at different levels of bait density and three distribution costs:cost-savings ratios for the expanding circles scenario Notes: Threshold price occurs at the point that the net present value of a vaccination program = $0. The distribution costs:cost-savings ratios are calculated on a per unit area basis, using the maximum cost-savings figures (i.e., savings resulting from avoiding an epizootic).

Main Article

Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external